While AID expression was shown to have implications in B-cell lymphomas [17, 18], which resemble a mature B-cells stage, aberrant AID activity could furthermore be linked to BCR-ABL positive leukemia [19], a disease affecting B-cell precursors. Here, AICDA is linked to leukemia.